Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure

Journal of Clinical Investigation

Volumn 95, Issue 2, 1995, Pages 619-627

  Duerr, Robert L ^a   Huang, Samuel ^a   Miraliakbar, Hamid R ^a   Clark, Ross ^c   Chien, Kenneth R ^a,b   Ross Jr , John ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; PLACEBO; RECOMBINANT SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CAPILLARY DENSITY; CELL SIZE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HEART FAILURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART OUTPUT; HEART STROKE VOLUME; HEART WEIGHT; INTRAPERITONEAL DRUG ADMINISTRATION; MICROANGIOGRAPHY; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; TIBIA;

EID: 0028799490     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/jci117706     Document Type: Article

References (56)

1. Schaper, J., and W. Schaper. 1983. Ultrastructural correlates of reduced cardiac function in human heart disease. Eur. Heart J. 4(Suppl. A):35-42.
2. Ross, J., Jr. 1976. Afterload mismatch and preload reserve: a conceptual framework for the analysis of ventricular function. Prog. Cardiovasc. Dis. 18:225-264.
3. Gerdes, A. M., S. E. Kellerman, J. A. Moore, K. E. Muffly, L. C. Clark, P. Y. Reaves, K. B. Malec, P. P. McKeown, and D. D. Schocken. 1992. Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy. Circulation. 86:426-430.
4. Olivetti, G., J. M. Capasso, L. G. Meggs, E. H. Sonnenblick, and P. Anversa. 1991. Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ. Res. 68:856-869.
5. Pfeffer, M. A., E. Braunwald, L. A. Moye, L. Basta, E. J. Brown, Jr., T. E. Cuddy, B. R. David, E. M. Geltman, S. Goldman, G. C. Flaker, et al. 1992. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N. Engl. J. Med. 327:669-677.
6. Baker, K. M., M. I. Chernin, S. K. Wixson, and J. F. Aceto. 1990, Reninangiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am. J. Physiol. 259 (Heart Circ. Physiol. 28):H324-H332.
7. Pfeffer, J. M., M. A. Pfeffer, and E. Brauwald. 1985. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ. Res. 57:84-95.
8. Rockman, H. A., S. P. Wachhorst, and J. Ross, Jr. 1994. Angiotensin II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. Am. J. Physiol. 266:H2468-H2475.
9. Chien, K. R. 1993. Molecular advances in cardiovascular biology. Science (Wash. DC). 260:916-917.
10. Chien, K. R., K. U. Knowlton, H. Zhu, and S. Chien. 1991. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of adaptive physiologic response (review). FASEB (Fed. Am. Soc. Exp. Biol.) J. 5:3037-3046.
11. Knowlton, K. U., E. Baracchini, R. S. Ross, A. N. Harris, S. A. Henderson, S. M. Evans, C. Glembotski, and K. R. Chien. 1991. Co-regulation of the atrial natriuretic factor and cardiac myosin light chain-2 genes during α-adrenergic stimulation of neonatal rat ventricular cells. J. Biol. Chem. 266:7759-7768.
12. 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of myocardial cell hypertrophy. J. Biol. Chem. 268:15374-15380.
13. Parker, T. G., S. E. Packer, and M. D. Schneider. 1990. Peptide growth factors can provoke fetal contractile protein gene expression in rat cardiac myocytes. J. Clin. Invest. 85:507-514.
14. Long, C. S., C. J. Henrich, and P. C. Simpson. 1991. A growth factor for cardiac myocytes is produced by cardiac nonmyocytes. Cell Regul. 2:1081-1095.
15. Rockman, H. A., S. Ono, R. S. Ross, L. R. Jones, M. Karimi, V. Bhargava, J. Ross, Jr., and K. R. Chien. 1994. Molecular and physiological alterations in murine ventricular dysfunction. Proc. Natl. Acad. Sci. USA. 91:2694-2698.
16. Shubeita, H. E., P. M. McDonough, A. Harris, K. U. Knowlton, C. Glembotski, J. H. Brown, and K. R. Chien. 1990. Endothelin induction of sarcomere assembly and cardiac gene expression in ventricular myocytes: a paracrine mechanism for myocardial cell hypertrophy. J. Biol. Chem. 265:20555-20562.
17. Schneider, M. D., and T. G. Parker. 1990. Cardiac myocytes as targets for the action of peptide growth factors. Circulation. 81:1443-1456.
18. Rinderknecht, E., and R. E. Humbel. 1978. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J. Biol. Chem. 253:2769-2776.
19. Mathews, L. S., G. Norstedt, and R. D. Palmiter. 1986. Regulation of insulin-like growth factor I gene expression by growth hormone. Proc. Natl. Acad. Sci. USA. 83:9343-9347.
20. Murphy, L. J., G. I. Bell, M. L. Duckworth, and H. G. Friesen. 1987. Identification, characterization and regulation of a rat complementary deoxyribonucleic acid which encodes insulin-like growth factor I. Endocrinology. 121:684-691.
21. Isgaard, J., C. Möller, O. G. Isaksson, A. Nilsson, L. S. Mathews, and G. Norstedt. 1988. Regulation of insulin-like growth factor messenger RNA in rat growth plate by growth hormone. Endocrinology. 122:1515-1520.
22. Ito, H., M. Hiroe, Y. Hirata, T. Motoyoshi, S. Adachi, S. Masayoshi, A. Koike, A. Nogami, and F. Marumo. 1993. Insulin like growth factor-1 induces hypertrophy with enhanced expression muscle specific genes in cultured rat cardiomyocytes. Circulation. 87:1715-1721.
23. Fuller, J., J. R. Mynett, and P. H. Sugden. 1992. Stimulation of cardiac protein synthesis by insulin-like growth factors. Biochem. J. 282:85-90.
24. Wahlander, H., J. Isgaard, E. Jennische, and P. Friberg. 1992. Left ventricular insulin-like growth factor I increases in early renal hypertension. Hypertension (Dallas). 19:25-32.
25. Donahue, T. J., M. D. Dworkin, M. N. Lango, K. Fliegner, R. P. Lango, J. A. Benstein, W. R. Slater, and V. M. Catanese. 1994. Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy. Circulation. 89:799-809.
26. Powell-Braxton, L., P. Hollingshead, C. Warburton, M. Dowd, S. Pitts-Meek, D. Dalton, N. Gillett, and T. Stewart. 1993. IGF-1 is required for normal embryonic growth in mice. Genes & Dev. 7:2609-2617.
27. Liu, J.-P., J. Baker, A. S. Perkins, E. J. Robertson, and A. Efstratiadis. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 75:59-72.
28. Lei, L.-Q., S. Rubin, and M. C. Fishbein. 1988. Cardiac architectural changes with hypertrophy induced by excess growth hormone in rats. Lab. Invest. 59:357-362.
29. Merola, B., A. Cittadini, A. Colao, S. Longobardi, S. Fazio, D. Sabatini, L. Sacca, and G. Lombardi. 1993. Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. J. Clin. Endocrinol. & Metab. 77:1658-1661.
30. Amato, G., C. Carella, S. Fazio, G. La Montagna, A. Cittadini, D. Sabatini, C. Marciano-Mone, L. Sacca, and A. Bellastella. 1993. Body composition, bone metabolism, and heart structure and function in growth hormone (GH) -deficient adults before and after GH replacement therapy at low doses. J. Clin. Endocrinol. & Metab. 77:1671-1676.
31. Theusen, L., S. E. Christensen, J. Weeke, H. Ørskov, and P. Henningsen. 1989. The cardiovascular effects of octreotide treatment in acromegaly: an echocardiographic study. Clin. Endocrinol. 30:619-625.
32. Chanson, P., J. Timsit, C. Masquet, A. Warnet, P.-J. Guillausseau, P. Birman, A. G. Harris, and J. Lubetzki. 1990. Cardiovascular effects of the somatostatin analog octreotide in acromegaly. Ann. Intern. Med. 113:921-925.
33. Shimatsu, A., and P. Rotwein. 1987. Mosaic evolution of the insulin-like growth factors: organization, sequence, and expression of the rat insulin-like growth factor I gene. J. Biol. Chem. 262:7894-7900.
34. Oh, B.-H., S. Ono, H. A. Rockman, and J. Ross, Jr. 1993. Myocardial hypertrophy in the ischemic zone induced by exercise in rats after coronary reperfusion. Circulation. 87:598-607.
35. Buñag, R. D., and J. Butterfield. 1982. Tail-cuff blood pressure measurement without external preheating in awake rats. Hypertension (Dallas). 4:898-903.
36. Ono, S., V. Bhargava, S. Ono, L. Mao, G. Hagan, H. A. Rockman, and J. Ross, Jr. 1994. In vivo assessment of left ventricular remodeling after myocardial infarction by digital video-contrast angiography in the rat. Cardiovasc. Res. 28:349-357.
37. Indolfi, C., B. D. Guth, T. Miura, S. Miyazaki, R. Schulz, and J. Ross, Jr. 1989. Mechanisms of improved ischemic regional dysfunction by bradycardia. Studies on UL-FS 49 in swine. Circulation. 80:983-993.
38. Miura, T., S. Miyazaki, B. D. Guth, M. Kambayashi, and J, Ross, Jr. 1992. Influence of the force-frequency relation on left ventricular function during exercise in conscious dogs. Circulation. 86:563-571.
39. Dodge, H. T., H. Sandler, D. W. Ballew, and J. D. Lord. 1960. The use of biplane angiocardiography for the measurement of left ventricular volume in man. Am. Heart J. 60:762-776.
40. Breier, B. H., B. W. Gallaher, and P. D. Gluckman. 1991. Radioimmunoassay for insulin-like growth factor-I: solutions to some potential problems and pitfalls. J. Endocrinol. 128:347-357.
41. Yin, R. C., H. A. Spurgeon, K. Rakusan, M. L. Weisfeldt, and E. G. Lakatta. 1982. Use of tibial length to quantify cardiac hypertrophy: application in the aging rat. Am. J. Physiol. 243:-H941-H947.
42. Dobler, P. C., and M. S. Spach. 1987. Thin collagenous septa in cardiac muscle. Anat. Rec. 218:445-455.
43. MacKenna, D. A., and J. H. Omens. 1994. A semi-automated method for measuring collagen area fraction and size distribution using picrosirius red. Am. J. Cardiovasc. Pathol. 5:165-180.
44. Pickering, J. G., and D. R. Boughner. 1990. Fibrosis in the transplanted heart and its relation to donor ischemic time: assessment with polarized light microscopy and digital image analysis. Circulation. 81:949-958.
45. White, F. C., E. A. Breish, L. E. Nimmo, G. Witzel, and C. M. Bloor. 1988. Regional capillary and myocyte density in normal and exercise trained male and female rat hearts. Am. J. Cardiovasc. Pathol. 2:247-253.
46. Chien, K. R., H. Zhu, K. U. Knowlton, W. Miller-Hance, M. van Bilsen, T. X. O'Brien, and S. Evans. 1993. Transcriptional regulation during cardiac growth and development. Annu. Rev. Physiol. 55:77-95.
47. Sadoshima, J., U. Zu, H. S. Slayter, and S. Izumo. 1993. Autocrine release of angiotensin II mediate stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 75:977-984.
48. Rubin, S. A., P. Buttrick, A. Malhotra, S. Melmed, and M. C. Fishbein. 1990. Cardiac physiology, biochemistry and morphology in response to excess growth hormone in the rat. J. Mol. Cell. Cardiol. 22:429-438.
49. Ballard, F. J., F. M. Tomas, L. C. Read, S. E. Knowles, P. C. Owens, A. B. Lemmey, A. A. Martin, J. R. E. Wells, J. C. Wallace, and G. L. Francis. 1991. Effects of IGF-1 and IGF analogs on growth during catabolic states in rats. In Modern Concepts of Insulin-Like Growth Factors. E. M. Spenser, editor. Elsevier Science Publishing Co., Inc., New York. 617-627.
50. Anversa, P., C. Beghi, Y. Kikkawa, and G. Olivetti. 1986. Myocardial infarction in rats. Infarct size, myocyte hypertrophy, and capillary growth. Circ. Res. 58:26-37.
51. Zimmer, H.-G., A. M. Gerdes, S. Lortet, and G. Mall. 1990. Changes in heart function and cell size in rats with chronic myocardial infarction. J. Mol. Cell. Cardiol. 22:1231-1243.
52. Ambler, G. R., B. M. Johnston, L. Maxwell, J. B. Gavin, and P. D. Gluckman. 1993. Improvement of doxorubicin induced cardiomyopathy in rats treated with insulin-like growth factor I. Cardiovasc. Res. 27:1368-1373.
53. Gay, R. G., S. Graham, M. Aguire, S. Goldman, and E. Morkin. 1988. Effects of 10- to 12-day treatment with L-thyroxine in rats with myocardial infarction. Am. J. Physiol. 255:H801-H806.
54. Litwin, S. E., T. E. Raya, P. G. Anderson, C. M. Litwin, R. Bresler, and S. Goldman. 1991. Induction of myocardial hypertrophy after coronary ligation in rats decreases ventricular dilatation and improves systolic function. Circulation. 84:1819-1827.
55. Omens, J. H., H. R. Rockman, and J. W. Covell. 1994. Passive ventricular mechanics in tight-skin mice. Am. J. Physiol. 266:H1-H8.
56. Wright, A. J. A., O. Hudlicka, and M. D. Brown. 1989. Beneficial effect of chronic bradycardial pacing on capillary growth and heart performance in volume overload heart hypertrophy. Circ. Res. 64:1205-1212.